Submitted:
12 October 2024
Posted:
12 October 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Study Design and Setting
2.2. Study Population
2.3. Definitions and Variables
2.4. Statistical Analysis
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- Peach BC, Garvan GJ, Garvan CS, Cimiotti JP. Risk factors for urosepsis in older adults: a systematic review. Gerontol Geriatric Med. 2016, 2.
- Foxman, B. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect Dis Clin North Am. 2014, 28, 1–13. [Google Scholar] [CrossRef] [PubMed]
- Van Duin, D. Diagnostic challenges and opportunities in older adults with infectious diseases. Clin Infect Dis. 2012, 54, 973–978. [Google Scholar] [CrossRef]
- Lee, J. H. , Lee, Y. M. & Cho, J. H. Risk factors of septic shock in bacteremic acute pyelonephritis patients admitted to an ER. J. Infect. Chemother. 2012, 18, 130–133. [Google Scholar]
- Esteve-Palau, E.; et al. Impact of an antimicrobial stewardship program on urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli. Rev. Esp. Quimioter. 2018, 31, 110–117. [Google Scholar]
- Flores-Mireles, A. , Walker, J., Caparon, M. & Hultgren, S. Urinary tract infections: Epidemiology, mechanisms of infection and treatment options. Nat. Rev. Microbiol. 2015, 13, 269–284. [Google Scholar]
- Gharbi, M.; et al. Antibiotic management of urinary tract infection in elderly patients in primary care and its association with bloodstream infections and all cause mortality: Population based cohort study. BMJ. [CrossRef]
- Horcajada, J. P.; et al. Healthcare-associated, community-acquired and hospital-acquired bacteraemic urinary tract infections in hospitalized patients: A prospective multicentre cohort study in the era of antimicrobial resistance. Clin. Microbiol. Infect. 2013, 19, 962–968. [Google Scholar] [CrossRef]
- Lee, J. H. , Lee, Y. M. & Cho, J. H. Risk factors of septic shock in bacteremic acute pyelonephritis patients admitted to an ER. J. Infect. Chemother. 2012, 18, 130–133. [Google Scholar]
- Schreiber, P. W.; et al. The preventable proportion of healthcare-associated infections 2005–2016: Systematic review and meta-analysis. Infect. Control Hosp. Epidemiol. 2018, 39, 1277–1295. [Google Scholar] [CrossRef]
- Ha, Y. E.; et al. Epidemiology and clinical outcomes of bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli in patients with cancer. Int. J. Antimicrob. Agents. 2012, 42, 403–409. [Google Scholar] [CrossRef] [PubMed]
- Wagenlehner F, Wullt B, Ballarini S, Zingg D, Naber KG. Social and economic burden of recurrent urinary tract infections and quality of life: a patient web-based study (GESPRIT) Expert Rev Pharmacoecon Outcomes Res. 2018, 18, 107–117. [CrossRef]
- Bader MS, Loeb M, Brooks AA. An update on the management of urinary tract infections in the era of antimicrobial resistance. Postgrad Med. 2017, 129, 242–258. [Google Scholar] [CrossRef]
- Wawrysiuk S, Naber K, Rechberger T, Miotla P. Prevention and treatment of uncomplicated lower urinary tract infections in the era of increasing antimicrobial resistance-non-antibiotic approaches: a systemic review. Arch Gynecol Obstet. 2019, 300, 821–828. [Google Scholar] [CrossRef]
- Fagan M, Lindbæk M, Grude N, et al. Antibiotic resistance patterns of bacteria causing urinary tract infections in the elderly living in nursing homes versus the elderly living at home: an observational study. BMC Geriatr. 2015, 15, 98. [Google Scholar]
- Detweiler K, Mayers D, Fletcher SG. Bacteruria and urinary tract infections in the elderly. Urol Clin North Am. 2015, 42, 561–568. [Google Scholar] [CrossRef]
- Jackson SL, Boyko EJ, Scholes D, Abraham L, Gupta K, Fihn SD. Predictors of urinary tract infection after menopause: a prospective study. Am J Med. 2004, 117, 903–911. [Google Scholar] [CrossRef]
- Foxman, B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon. 2013, 49, 53–70. [Google Scholar] [CrossRef]
- Rowe TA, Juthani-Mehta M. Diagnosis and management of urinary tract infection in older adults. Infect Dis Clin North Am. 2014, 28, 75–89. [Google Scholar] [CrossRef]
- Dason S, Dason JT, Kapoor A. Guidelines for the diagnosis and management of recurrent urinary tract infection in women. Can Urol Assoc J. 2011, 5, 316–22. [Google Scholar]
- Vallejo-Torres L, Pujol M, Shaw E, et al. Cost of hospitalised patients due to complicated urinary tract infections: a retrospective observational study in countries with high prevalence of multidrug-resistant Gram-negative bacteria: the COMBACTE-MAGNET, RESCUING study. BMJ Open. 2018, 8, e020251. [Google Scholar] [CrossRef] [PubMed]
- Bader MS, Loeb M, Brooks AA. An update on the management of urinary tract infections in the era of antimicrobial resistance. Postgrad Med. 2017, 129, 242–258. [Google Scholar] [CrossRef] [PubMed]
- Wawrysiuk S, Naber K, Rechberger T, Miotla P. Prevention and treatment of uncomplicated lower urinary tract infections in the era of increasing antimicrobial resistance-non-antibiotic approaches: a systemic review. Arch Gynecol Obstet. 2019, 300, 821–828. [Google Scholar] [CrossRef] [PubMed]
- Veeraraghavan, B. , Bakthavatchalam Y.D., Sahni R.D. Oral Antibiotics in Clinical Development for Community-Acquired Urinary Tract Infections. Infect. Dis. Ther. 2021, 10, 1815–1835. [Google Scholar] [CrossRef]
- Dason, S. , Dason J.T., Kapoor A. Guidelines for the diagnosis and management of recurrent urinary tract infection in women. Can. Urol. Assoc. 2015, 5, 316–322. [Google Scholar] [CrossRef]
- Bader, M.S. , Loeb M., Leto D., Brooks A.A. Treatment of urinary tract infections in the era of antimicrobial resistance and new antimicrobial agents. Postgrad. Med. 2020, 132, 234–250. [Google Scholar] [CrossRef]
- Li, X. , Fan H., Zi H., Hu H., Li B., Huang J., Luo P., Zeng X. Global and Regional Burden of Bacterial Antimicrobial Resistance in Urinary Tract Infections in 2019. J. Clin. Med. 2022, 11, 2817. [Google Scholar] [CrossRef]
- van Buul, L.W. , Vreeken H.L., Bradley S.F., Crnich C.J., Drinka P.J., Geerlings S.E., Jump R.L.P., Mody L., Mylotte J.J., Loeb M., et al. The Development of a Decision Tool for the Empiric Treatment of Suspected Urinary Tract Infection in Frail Older Adults: A Delphi Consensus Procedure. J. Am. Med. Dir. Assoc. 2018, 19, 757–764. [Google Scholar] [CrossRef]
- Staerk, K. , Khandige S., Kolmos H.J., Moller-Jensen J., Andersen T.E. Uropathogenic Escherichia coli Express Type 1 Fimbriae Only in Surface Adherent Populations Under Physiological Growth Conditions. J. Infect. Dis. 2016, 213, 386–394. [Google Scholar] [CrossRef]
- Shah, C. , Baral R., Bartaula B., Shrestha L.B. Virulence factors of uropathogenic Escherichia coli (UPEC) and correlation with antimicrobial resistance. BMC Microbiol. 2019, 19, 204. [Google Scholar] [CrossRef]
- Behzadi, P. Classical chaperone-usher (CU) adhesive fimbriome: Uropathogenic Escherichia coli (UPEC) and urinary tract infections (UTIs). Folia Microbiol. 2020, 65, 45–65. [Google Scholar] [CrossRef] [PubMed]
- Lee, D.S. , Lee S.J., Choe H.S. Community-Acquired Urinary Tract Infection by Escherichia coli in the Era of Antibiotic Resistance. BioMed Res. Int. 2018, 2018, 7656752. [Google Scholar] [CrossRef] [PubMed]
- Effah, C.Y.; , Sun T., Liu S., Wu Y. Klebsiella pneumoniae: An increasing threat to public health. Ann. Clin. Microbiol. Antimicrob. 2020, 19, 1. [Google Scholar] [CrossRef] [PubMed]
- Qin, S.; , Xiao W., Zhou C., Pu Q., Deng X., Lan L., Liang H., Song X., Wu M. Pseudomonas aeruginosa: Pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics. Signal Transduct. Target. Ther. 2022, 7, 199. [Google Scholar] [CrossRef] [PubMed]
| Parameter | Total UTI n(%) N= 948 |
|---|---|
| Chronic renal disease | 237 (25) |
| Hypertension | 587 (61.9) |
| Urinary tract obstruction | 65 (6.8) |
| Nephrolithiasis | 189 (19.9) |
| Malignancies | 131 (13.8) |
| Heart failure | 101(10.6) |
| Stroke | 154(16.2) |
| Diabetes mellitus | 206 (21.7) |
| HIV | 52 (5.4) |
| Malnutrition | 115 (12.1) |
| Cardiovascular disease | 241 (25.4) |
| Hypertrophic prostate disease | 146 (15.4) |
| Hospitalization 30 days prior | 301 (31.7) |
| Parameter | Total UTI n(%) N= 948 |
|---|---|
| Tachycardia | 480 (50.6) |
| Fever | 798 (84.1) |
| Sepsis | 165 (17.4) |
| Haematuria | 411 (43.3) |
| Elevated CRP | 841 (88.7) |
| Leukocytosis | 791 (83.4) |
| Hypotension | 452(47.6) |
| Acute kidney injury | 272 (28.6) |
| Positive urine nitrites | 305 (32.1) |
| Leukocyturia | 832 (87.7) |
| Neutrophilia | 696 (73.4) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).